Four-Year Experience of Use of the Cobas Amplicor System for Rapid Detection of Mycobacterium tuberculosis Complex in Respiratory and Nonrespiratory Specimens in Greece
- 1 June 2003
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 22 (6) , 349-356
- https://doi.org/10.1007/s10096-003-0931-5
Abstract
To evaluate the experience of a clinical microbiology laboratory with a DNA amplification assay for routine detection of Mycobacterium tuberculosis, the Cobas Amplicor Mycobacterium tuberculosis (MTB) polymerase chain reaction (PCR) assay (Roche Diagnostics Systems, USA) was performed on 7,722 respiratory and 1,451 nonrespiratory specimens collected from 3,321 patients. The results were compared with those of culture in conventional Lowenstein-Jensen medium, culture in the MB/BacT system (Organon Teknika, France), and clinical investigations. A total of 240 of the 254 respiratory specimens culture positive for Mycobacterium tuberculosis were also positive in the PCR assay. Of the 7,300 culture-negative specimens, 45 (0.6%) were positive in the PCR. After detailed interpretation, the overall sensitivity, specificity, and positive and negative predictive values of the PCR assay were 84.5, 99.8, 94.1, and 99.4%, respectively, for respiratory specimens. The PCR assay was more sensitive for smear-positive respiratory specimens (97.1%) than for smear-negative respiratory specimens (48.6%). Of the 18 culture-positive (smear-negative) nonrespiratory specimens, 9 were positive in the PCR. None of the 1,384 culture-negative nonrespiratory specimens were positive in the PCR. The inhibition rates detected by the internal control of the test were 2.2% for respiratory specimens and 3.4% for nonrespiratory specimens. After resolving the discrepancies, the overall sensitivity, specificity, and positive and negative predictive values of the PCR assay were 82.5, 99.8, 94.3, and 99.4%, respectively, when compared to the results of diagnostic culture. In conclusion, the use of the Cobas Amplicor MTB-PCR assay might enable clinical microbiology laboratories with considerable previous experience in molecular biology testing to perform PCR and confirm tuberculosis infection immediately, leading to improved patient management.Keywords
This publication has 9 references indexed in Scilit:
- Multicenter Study of a Commercial, Automated Polymerase Chain Reaction System for the Rapid Detection of Mycobacterium tuberculosis in Respiratory Specimens in Routine Clinical PracticeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2001
- Evaluation of Commercial DNA and rRNA Amplification Assays for Assessment of Treatment Outcome in Pulmonary Tuberculosis PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2001
- Improved detection and differentiation of mycobacteria with combination of Mycobacterium Growth Indicator Tube and Roche COBAS AMPLICOR System in conjunction with Duplex PCRJournal of Microbiological Methods, 2001
- Performance Assessment of New Multiplex Probe Assay for Identification of MycobacteriaJournal of Clinical Microbiology, 2001
- Update: Nucleic acid amplification tests for tuberculosis.2000
- Multicenter evaluation of two commercial amplification kits (Amplicor, Roche and LCx, Abbott) for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary specimensDiagnostic Microbiology and Infectious Disease, 1999
- Strand Displacement Amplification and the Polymerase Chain Reaction for Monitoring Response to Treatment in Patients with Pulmonary TuberculosisThe Journal of Infectious Diseases, 1996
- The new diagnostic mycobacteriology laboratoryEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- SPUTUM DIGESTION AND DECONTAMINATION WITH N-ACETYL-L-CYSTEINE - SODIUM HYDROXIDE FOR CULTURE OF MYCOBACTERIAPublished by Elsevier ,1963